We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

38 hedge funds and large institutions have $97.3M invested in Axcella Health Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

14% less funds holding

Funds holding: 4438 (-6)

20% less capital invested

Capital invested by funds: $122M → $97.3M (-$24.3M)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

67% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 18

Holders
38
Holders Change
-6
Holders Change %
-13.64%
% of All Funds
0.66%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
6
Reduced
18
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
-$2K -20 Closed
AIP
52
Ameritas Investment Partners
Nebraska
-$1K -6 Closed

AXLA Hedge Fund Activity: Q2 2021 in Review

38 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2021, worth a combined $97.3M — down 20% from $122M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AXLA and 8 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $353K. The largest seller was BlackRock, cutting an estimated $2.95M.

  • 38 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2021, down from 44 in Q1 2021.
  • Funds reported $97.3M of Axcella Health Inc. Common Stock stock for Q2 2021, down 20% quarter-over-quarter.
  • 8 funds opened new Axcella Health Inc. Common Stock positions in Q2 2021 and 14 closed out, a net change of -6 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q2 2021 was Renaissance Technologies, an estimated $353K added.
  • The largest Axcella Health Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $2.95M sold.

Based on aggregated 13F filings for Q2 2021.